Anne Marie Rousseau
About Anne Marie Rousseau
Anne Marie Rousseau is a Scientist at Bristol Myers Squibb in Seattle, Washington, with extensive experience in microbiology, immunology, and cancer biology.
Current Role at Bristol Myers Squibb
Anne Marie Rousseau currently works at Bristol Myers Squibb as a Scientist. She is based in Seattle, Washington, United States. In her role, she leverages her extensive experience in microbiology, immunology, and various scientific techniques to contribute to the company's research and development efforts.
Previous Experience at Celgene
Before joining Bristol Myers Squibb, Anne Marie Rousseau worked at Celgene as a Senior Associate Scientist from 2019 to 2020 for one year. She was based in the Greater Seattle Area and contributed to the company's scientific research initiatives during her tenure.
Extensive Tenure at Amgen
Anne Marie Rousseau had a significant tenure at Amgen, spanning from 2002 to 2014. She held various roles, including Senior Associate Scientist and Associate Scientist, across different departments such as Cancer Biology, Cancer Pharmacology, Therapeutic Innovations Unit, and Vascular Biology. Her work included developing biohazard safety protocols, utilizing multi-color flow cytometry analysis platforms, and optimizing in vitro cell-based assays.
Educational Background in Microbiology and Immunology
Anne Marie Rousseau studied at Washington State University, where she earned a Bachelor of Science degree in Microbiology and Immunology from 1984 to 1988. Prior to that, she attended Clark College from 1983 to 1985, achieving an Associate of Arts and Sciences degree in Biology. Her educational background laid a strong foundation for her career in scientific research.
Technical Skills and Expertise
Anne Marie Rousseau possesses a broad range of technical skills and expertise. She is proficient in using multi-color flow cytometry analysis platforms like Fortessa, Facscan, and Facscaliber. She has hands-on experience with long-term culture of cells, in vitro expansion of Tregs, and developing and optimizing ELISAs. Additionally, she is experienced in using real-time imaging platforms like ZOOM and FLR Incucyte, and has extensive knowledge of leukopack processing and cell purification techniques.